Bentham Science Logo

Recent Patents on Anti-Infective Drug Discovery

Volume 14, 3 Issues, 2019
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access

Aims & Scope

Recent Patents on Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery.

Recent Patents on Anti-Infective Drug Discovery

,

Volume 13

-

Number 3



Biography   Open Access



Review Article



Review Article



Review Article



Research Article

HIV/AIDS Curable Study: New Forms of Therapeutic Trinity

, 13(3): 217 - 227

Da-Yong Lu*, Ting-Ren Lu, Hong-Ying Wu, Nagendra S. Yarla, Jian Ding and Bin Xu


DOI: 10.2174/1574891X13666181026094526


Research Article

Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients

, 13(3): 228 - 239

Mehran Izadi, Banafsheh Dadsetan, Zeinab Najafi, Sirous Jafari, Elham Mazaheri, Omid Dadras, Hajar Heidari, SeyedAhmad SeyedAlinaghi* and Fabricio Voltarelli


DOI: 10.2174/1574891X13666181024154526


Research Article

In Vitro Anti-mycobacterial Activity of Three Medicinal Plants of Lamiaceae Family

, 13(3): 240 - 245

Hossein Kazemian, Hamid Heidari, Jalil Kardan Yamchi, Hengameh Zandi, Asieh Taji, Fateme Yazdani, Gholamreza Hamzehloo, Roya Ghanavati, Hossein A. Rahdar and Mohammad M. Feizabadi*


DOI: 10.2174/1574891X13666180626170155


Research Article



Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Published Contents

Editor's Choice

Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients

, 2018; 13(3): 190 - 197

Niccolò Riccardi, Marco Berruti, Filippo Del Puente, Lucia Taramasso and Antonio Di Biagio*


DOI: 10.2174/1574891X13666181031120019



Nano-Based Therapy for Treatment of Skin Cancer

, 2018; 13(2): 151 - 163

Sadaf J. Gilani, Mohammed A. Jahangir, Chandrakala, Md. Rizwanullah, Mohamad Taleuzzaman, Mohammad S. Shahab, Kashif Shakeel, Mohd. Aqil and Syed S. Imam*


DOI: 10.2174/1574891X13666180911095440



Short Antimicrobial Peptides

, 2018; 13(1): 12 - 52

Komal Sharma, Shams Aaghaz, Kitika Shenmar and Rahul Jain*


DOI: 10.2174/1574891X13666180628105928




3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis

, 2017; 12(1): 3 - 7

Saeed Hemati, Sobhan Ghafourian, Nourkhoda Sadeghfard, Zahra Mahdavi, Abbas Maleki, Fatemeh Sayehmiri, Kouroush Sayehmiri, Lidija Bogdanovic and Morovat Taherikalani*


DOI: 10.2174/1574891X12666170130101006




Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis

, 2016; 11(1): 3 - 15

Mahfoozur Rahman, Sarwar Beg, Gajanand Sharma, Sumant Saini, Rehan A. Rub, Preeti Aneja, Firoz Anwar, Mohammad A. Alam and Vikas Kumar


DOI: 10.2174/1574891X1101160511195513





Dengue Patients Treated with Doxycycline Showed Lower Mortality Associated to a Reduction in IL-6 and TNF Levels

, 2015; 10(1): 51 - 58

Terry M. Fredeking, Jorge E. Zavala-Castro, Pedro Gonzalez-Martinez, William Moguel-Rodríguez, Ernesto C. Sanchez, Michael J. Foster and Fredi A. Diaz-Quijano


DOI: 10.2174/1574891X10666150410153839



Open Access Articles

Topical Nanoemulgel for Skin Disorders: Formulation Approach and Characterization

, 2019; 14: 1 - 13 (E-Pub Ahead of Print)

Javed Ahmad*, Anuj Gautam, Shahadali Komath, Mehdiya Bano, Anuj Garg and Keerti Jain






Topical Antimicrobials for Burn Infections – An Update

, 2013; 8(3): 161 - 197

Mert Sevgi, Ani Toklu, Daniela Vecchio and Michael R. Hamblin




Liposome-Encapsulated Photosensitizers Against Bacteria

, 2013; 8(2): 100 - 107

Chin-Tin Chen, Chueh-Pin Chen, Jen-Chang Yang and Tsuimin Tsai





Most Cited Articles

Review Article

Current state of nanomedicines in the treatment of topical infectious disorders

, 2018; 13(2): 127-150.

Kanika Thakur, Gajanand Sharma, Bhupinder Singh, Sanjay Chhibber and Om P. Katare*


DOI: 10.2174/1574891X13666180529103804


Review Article

Current progress in synthesis, characterization and applications of silver nanoparticles: Precepts and prospects

, 2018; 13(1): 53-69.

Md. Abul Barkat, Harshita, Sarwar Beg, Mohd. Javed Naim, Faheem H. Pottoo, Satya P. Singh and Farhan J. Ahmad*


DOI: 10.2174/1574891X12666171006102833


Research Article

In vitro anti-mycobacterial activity of three medicinal plants of lamiaceae family

, 2018; 13(3): 240-245.

Hossein Kazemian, Hamid Heidari, Jalil Kardan Yamchi, Hengameh Zandi, Asieh Taji, Fateme Yazdani, Gholamreza Hamzehloo, Roya Ghanavati, Hossein A. Rahdar and Mohammad M. Feizabadi*


DOI: 10.2174/1574891X13666180626170155


Review Article

Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens

, 2018; 13(1): 3-11.

Niccolò Riccardi*, Filippo Del Puente, Federica Magnè , Lucia Taramasso and Antonio Di Biagio


DOI: 10.2174/1574891X12666170619101904


Review Article

Recent patents on light-based anti-infective approaches

, 2018; 13(1): 70-88.

Imran Ahmed, Yanyan Fang, Min Lu, Quan Yan, Ahmed El-Hussein, Michael R. Hamblin and Tianhong Dai*


DOI: 10.2174/1872213X11666171108104104


Review Article

New drugs and vaccines for tuberculosis

, 2018; 12(2): 147-161.

Praveen K. Gaur* and Shikha Mishra


DOI: 10.2174/1574891X12666171006105921


Research Article

Antibacterial activity of gold nanoparticles conjugated by aminoglycosides against A. Baumannii isolates from burn patients

, 2018; 13(3): 256-264.

Mehdi Rostami rad, Hossein Kazemian, Fateme Yazdani, Mohammad Reza Zand Monfared, Hoseinali Rahdar, Ali Javadi* and Mansoor Kodori*


DOI: 10.2174/1574891X13666180828115543


Research Article

HIV/AIDS curable study: New forms of therapeutic trinity

, 2018; 13(3): 217-227.

Da-Yong Lu*, Ting-Ren Lu, Hong-Ying Wu, Nagendra S. Yarla, Jian Ding and Bin Xu


DOI: 10.2174/1574891X13666181026094526




Review Article

Biological efficacy of carvacrol analogues

, 2018; 13(3): 207-216.

Zintle Mbese and Blessing Atim Aderibigbe*


DOI: 10.2174/1574891X14666181205111821


Review Article

Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients

, 2018; 13(3): 190-197.

Niccolò Riccardi, Marco Berruti, Filippo Del Puente, Lucia Taramasso and Antonio Di Biagio*


DOI: 10.2174/1574891X13666181031120019


Research Article

Levofloxacin versus ceftriaxone and azithromycin combination in the treatment of community acquired pneumonia in hospitalized patients

, 2018; 13(3): 228-239.

Mehran Izadi, Banafsheh Dadsetan, Zeinab Najafi, Sirous Jafari, Elham Mazaheri, Omid Dadras, Hajar Heidari, SeyedAhmad SeyedAlinaghi* and Fabricio Voltarelli


DOI: 10.2174/1574891X13666181024154526


Review Article

Nano-based therapy for treatment of skin cancer

, 2018; 13(2): 151-163.

Sadaf J. Gilani, Mohammed A. Jahangir, Chandrakala, Md. Rizwanullah, Mohamad Taleuzzaman, Mohammad S. Shahab, Kashif Shakeel, Mohd. Aqil and Syed S. Imam*


DOI: 10.2174/1574891X13666180911095440


General Research Article

Evaluation of fosfomycin activity against extended spectrum beta lactamase (ESBL) producing enterobacteriaceae isolated from three centers of Tehran, Iran

, 2018; 13(2): 180-186.

Roya Ghanavati, Elnaz Ohadi, Hossein Kazemian, Fateme Yazdani, Alireza Torki, Behrooz S. Kalani and Gholamreza Irajian*


DOI: 10.2174/1574891X13666180517075803



Most Accessed Articles

Short Antimicrobial Peptides

, 2018; 13(1): 12-52.

Komal Sharma, Shams Aaghaz, Kitika Shenmar and Rahul Jain*


DOI: 10.2174/1574891X13666180628105928



Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients

, 2018; 13(3): 190-197.

Niccolò Riccardi, Marco Berruti, Filippo Del Puente, Lucia Taramasso and Antonio Di Biagio*


DOI: 10.2174/1574891X13666181031120019


Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients

, 2018; 13(3): 228-239.

Mehran Izadi, Banafsheh Dadsetan, Zeinab Najafi, Sirous Jafari, Elham Mazaheri, Omid Dadras, Hajar Heidari, SeyedAhmad SeyedAlinaghi* and Fabricio Voltarelli


DOI: 10.2174/1574891X13666181024154526


HIV/AIDS Curable Study: New Forms of Therapeutic Trinity

, 2018; 13(3): 217-227.

Da-Yong Lu*, Ting-Ren Lu, Hong-Ying Wu, Nagendra S. Yarla, Jian Ding and Bin Xu


DOI: 10.2174/1574891X13666181026094526



Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens

, 2018; 13(1): 3-11.

Niccolò Riccardi*, Filippo Del Puente, Federica Magnè, Lucia Taramasso and Antonio Di Biagio


DOI: 10.2174/1574891X12666170619101904




Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against A. baumannii Isolates from Burn Patients

, 2018; 13(3): 256-264.

Mehdi Rostami Rad, Hossein Kazemian, Fateme Yazdani, Mohammad Reza Zand Monfared, Hoseinali Rahdar, Ali Javadi* and Mansoor Kodori*


DOI: 10.2174/1574891X13666180828115543




Editor-in-Chief

Dieter Kabelitz
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
Germany

Journal History

Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Dieter Kabelitz serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog